{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:37:47Z","timestamp":1792291067998,"version":"4.4.0"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T00:00:00Z","timestamp":1751241600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T00:00:00Z","timestamp":1751241600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s40257-025-00960-w","type":"journal-article","created":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T02:00:48Z","timestamp":1751248848000},"page":"747-759","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Alopecia in Children with Cancer: A Review from Pathophysiology to Management"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9851-1276","authenticated-orcid":false,"given":"Caitlin A.","family":"Kearney","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciara A.","family":"Maguire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikash S.","family":"Oza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina S.","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Occidental","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth J.","family":"Orlow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chana L.","family":"Glasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario E.","family":"Lacouture","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikita R.","family":"Lakdawala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen I.","family":"Lo Sicco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,30]]},"reference":[{"issue":"2","key":"960_CR1","first-page":"139","volume":"5","author":"K M\u00fcnstedt","year":"1997","unstructured":"M\u00fcnstedt K, Manthey N, Sachsse S, Vahrson H. Changes in self-concept and body image during alopecia induced cancer chemotherapy. Support Care Cancer. 1997;5(2):139\u201343.","journal-title":"Support Care Cancer"},{"issue":"6","key":"960_CR2","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1046\/j.1523-5394.2001.96007.x","volume":"9","author":"EL McGarvey","year":"2001","unstructured":"McGarvey EL, Baum LD, Pinkerton RC, Rogers LM. Psychological sequelae and alopecia among women with cancer. Cancer Pract. 2001;9(6):283\u20139.","journal-title":"Cancer Pract"},{"issue":"4","key":"960_CR3","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1097\/SPC.0b013e3283409280","volume":"4","author":"RM Tr\u00fceb","year":"2010","unstructured":"Tr\u00fceb RM. Chemotherapy-induced alopecia. Curr Opin Support Palliat Care. 2010;4(4):281\u20134.","journal-title":"Curr Opin Support Palliat Care"},{"issue":"5","key":"960_CR4","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/j.jaad.2018.03.055","volume":"80","author":"A Freites-Martinez","year":"2019","unstructured":"Freites-Martinez A, Shapiro J, Goldfarb S, Nangia J, Jimenez JJ, Paus R, et al. Hair disorders in patients with cancer. J Am Acad Dermatol. 2019;80(5):1179\u201396.","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"960_CR5","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1001\/jamadermatol.2020.2127","volume":"156","author":"GS Phillips","year":"2020","unstructured":"Phillips GS, Freret ME, Friedman DN, Trelles S, Kukoyi O, Freites-Martinez A, et al. Assessment and treatment outcomes of persistent radiation-induced alopecia in patients with cancer. JAMA Dermatol. 2020;156(9):963\u201372.","journal-title":"JAMA Dermatol"},{"issue":"3","key":"960_CR6","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.jpainsymman.2012.09.012","volume":"46","author":"L Hed\u00e9n","year":"2013","unstructured":"Hed\u00e9n L, P\u00f6der U, von Essen L, Ljungman G. Parents\u2019 perceptions of their child\u2019s symptom burden during and after cancer treatment. J Pain Symptom Manage. 2013;46(3):366\u201375.","journal-title":"J Pain Symptom Manage"},{"issue":"3","key":"960_CR7","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/j.1525-1470.1987.tb00775.x","volume":"4","author":"JH Barth","year":"1987","unstructured":"Barth JH. Normal hair growth in children. Pediatr Dermatol. 1987;4(3):173\u201384.","journal-title":"Pediatr Dermatol"},{"issue":"1","key":"960_CR8","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/S0738-081X(01)00226-7","volume":"20","author":"MS Wade","year":"2002","unstructured":"Wade MS, Sinclair RD. Disorders of hair in infants and children other than alopecia. Clin Dermatol. 2002;20(1):16\u201328.","journal-title":"Clin Dermatol"},{"issue":"2","key":"960_CR9","doi-asserted-by":"publisher","first-page":"e50","DOI":"10.1016\/S1470-2045(12)70553-3","volume":"14","author":"R Paus","year":"2013","unstructured":"Paus R, Haslam IS, Sharov AA, Botchkarev VA. Pathobiology of chemotherapy-induced hair loss. Lancet Oncol. 2013;14(2):e50\u20139.","journal-title":"Lancet Oncol"},{"issue":"1","key":"960_CR10","doi-asserted-by":"publisher","first-page":"e37","DOI":"10.1016\/j.jaad.2011.02.026","volume":"67","author":"SY Chon","year":"2012","unstructured":"Chon SY, Champion RW, Geddes ER, Rashid RM. Chemotherapy-induced alopecia. J Am Acad Dermatol. 2012;67(1):e37-47.","journal-title":"J Am Acad Dermatol"},{"key":"960_CR11","doi-asserted-by":"publisher","first-page":"117727191984218","DOI":"10.1177\/1177271919842180","volume":"14","author":"IS Haslam","year":"2019","unstructured":"Haslam IS, Smart E. Chemotherapy-induced hair loss: the use of biomarkers for predicting alopecic severity and treatment efficacy. Biomark Insights. 2019;14:1177271919842180.","journal-title":"Biomark Insights."},{"issue":"4","key":"960_CR12","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1097\/DAD.0b013e3181fcfc25","volume":"33","author":"M Miteva","year":"2011","unstructured":"Miteva M, Misciali C, Fanti PA, Vincenzi C, Romanelli P, Tosti A. Permanent alopecia after systemic chemotherapy: a clinicopathological study of 10 cases. Am J Dermatopathol. 2011;33(4):345\u201350.","journal-title":"Am J Dermatopathol"},{"issue":"6","key":"960_CR13","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1590\/abd1806-4841.20154013","volume":"90","author":"FM Basilio","year":"2015","unstructured":"Basilio FM, Brenner FM, Werner B, Rastelli GJ. Clinical and histological study of permanent alopecia after bone marrow transplantation. An Bras Dermatol. 2015;90(6):814\u201321.","journal-title":"An Bras Dermatol"},{"issue":"3","key":"960_CR14","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.ad.2014.07.006","volume":"106","author":"C Bern\u00e1rdez","year":"2015","unstructured":"Bern\u00e1rdez C, Molina-Ruiz AM, Requena L. Histologic features of alopecias-part I: nonscarring alopecias. Actas Dermosifiliogr. 2015;106(3):158\u201367.","journal-title":"Actas Dermosifiliogr"},{"issue":"1","key":"960_CR15","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"960_CR16","first-page":"83","volume":"64","author":"E Ward","year":"2014","unstructured":"Ward E, DeSantis C, Robbins A, Kohler B, Jemal A. Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin. 2014;64(2):83\u2013103.","journal-title":"CA Cancer J Clin"},{"key":"960_CR17","doi-asserted-by":"publisher","first-page":"e2200034","DOI":"10.1200\/GO.22.00034","volume":"8","author":"AE Denburg","year":"2022","unstructured":"Denburg AE, Fundytus A, Khan MS, Howard SC, Antillon-Klussmann F, Sengar M, et al. Defining essential childhood cancer medicines to inform prioritization and access: results from an international, cross-sectional survey. J Glob Oncol. 2022;8:e2200034.","journal-title":"J Glob Oncol."},{"issue":"7","key":"960_CR18","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1038\/bmt.2017.15","volume":"52","author":"D Bresters","year":"2017","unstructured":"Bresters D, Wanders DCM, Louwerens M, Ball LM, Fiocco M, van Doorn R. Permanent diffuse alopecia after haematopoietic stem cell transplantation in childhood. Bone Marrow Transplant. 2017;52(7):984\u20138.","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"960_CR19","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1002\/pon.3531","volume":"23","author":"EK Choi","year":"2014","unstructured":"Choi EK, Kim IR, Chang O, Kang D, Nam SJ, Lee JE, et al. Impact of chemotherapy-induced alopecia distress on body image, psychosocial well-being, and depression in breast cancer patients. Psychooncology. 2014;23(10):1103\u201310.","journal-title":"Psychooncology"},{"issue":"4","key":"960_CR20","first-page":"347","volume":"12","author":"M Vowels","year":"1993","unstructured":"Vowels M, Chan LL, Giri N, Russell S, Lam-Po-Tang R. Factors affecting hair regrowth after bone marrow transplantation. Bone Marrow Transplant. 1993;12(4):347\u201350.","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"960_CR21","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/pde.14418","volume":"38","author":"D Sous","year":"2021","unstructured":"Sous D, Armstrong AE, Huang JT, Shah S, Carlberg VM, Coughlin CC. Cutaneous reactions to pediatric cancer treatment: part I. Conventional chemotherapy. Pediatr Dermatol. 2021;38(1):8\u201317.","journal-title":"Pediatr Dermatol"},{"key":"960_CR22","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/S0022-3476(62)80341-2","volume":"61","author":"MJ Sweeney","year":"1962","unstructured":"Sweeney MJ, Tuttle AH, Etteldorf JN, Whittington GL. Cyclophosphamide in the treatment of common neoplastic diseases of childhood. J Pediatr. 1962;61:702\u20138.","journal-title":"J Pediatr"},{"issue":"1","key":"960_CR23","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1542\/peds.38.1.82","volume":"38","author":"RM Heyn","year":"1966","unstructured":"Heyn RM, Beatty EC Jr, Hammond D, Louis J, Pierce M, Murphy ML, et al. Vincristine in the treatment of acute leukemia in children. Pediatrics. 1966;38(1):82\u201391.","journal-title":"Pediatrics"},{"issue":"5","key":"960_CR24","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1002\/pbc.25429","volume":"62","author":"VR Belum","year":"2015","unstructured":"Belum VR, Washington C, Pratilas CA, Sibaud V, Boralevi F, Lacouture ME. Dermatologic adverse events in pediatric patients receiving targeted anticancer therapies: a pooled analysis. Pediatr Blood Cancer. 2015;62(5):798\u2013806.","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"960_CR25","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/pde.14495","volume":"38","author":"VM Carlberg","year":"2021","unstructured":"Carlberg VM, Davies OMT, Brandling-Bennett HA, Leary SES, Huang JT, Coughlin CC, et al. Cutaneous reactions to pediatric cancer treatment part II: targeted therapy. Pediatr Dermatol. 2021;38(1):18\u201330.","journal-title":"Pediatr Dermatol"},{"issue":"6","key":"960_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.27682","volume":"66","author":"H Song","year":"2019","unstructured":"Song H, Zhong CS, Kieran MW, Chi SN, Wright KD, Huang JT. Cutaneous reactions to targeted therapies in children with CNS tumors: a cross-sectional study. Pediatr Blood Cancer. 2019;66(6): e27682.","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"960_CR27","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1016\/j.jaad.2020.07.044","volume":"84","author":"CL Boull","year":"2021","unstructured":"Boull CL, Gardeen S, Abdali T, Li E, Potts J, Rubin N, et al. Cutaneous reactions in children treated with MEK inhibitors, BRAF inhibitors, or combination therapy: a multicenter study. J Am Acad Dermatol. 2021;84(6):1554\u201361.","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"960_CR28","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1200\/JCO.2010.30.7231","volume":"29","author":"R Aplenc","year":"2011","unstructured":"Aplenc R, Blaney SM, Strauss LC, Balis FM, Shusterman S, Ingle AM, et al. Pediatric phase I trial and pharmacokinetic study of dasatinib: a report from the children\u2019s oncology group phase I consortium. J Clin Oncol. 2011;29(7):839\u201344.","journal-title":"J Clin Oncol"},{"issue":"21","key":"960_CR29","doi-asserted-by":"publisher","first-page":"6011","DOI":"10.1158\/1078-0432.CCR-11-3284","volume":"18","author":"BC Widemann","year":"2012","unstructured":"Widemann BC, Kim A, Fox E, Baruchel S, Adamson PC, Ingle AM, et al. A phase I trial and pharmacokinetic study of sorafenib in children with refractory solid tumors or leukemias: a Children\u2019s Oncology Group Phase I Consortium report. Clin Cancer Res. 2012;18(21):6011\u201322.","journal-title":"Clin Cancer Res"},{"issue":"13","key":"960_CR30","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1016\/j.ejca.2009.03.007","volume":"45","author":"B Geoerger","year":"2009","unstructured":"Geoerger B, Morland B, Ndiaye A, Doz F, Kalifa G, Geoffray A, et al. Target-driven exploratory study of imatinib mesylate in children with solid malignancies by the Innovative Therapies for Children with Cancer (ITCC) European Consortium. Eur J Cancer. 2009;45(13):2342\u201351.","journal-title":"Eur J Cancer"},{"issue":"8","key":"960_CR31","doi-asserted-by":"publisher","first-page":"991","DOI":"10.3390\/ph17080991","volume":"17","author":"TH Jaing","year":"2024","unstructured":"Jaing TH, Wang YL, Chiu CC. Immune checkpoint inhibitors for pediatric cancers: is it still a stalemate? Pharmaceuticals (Basel). 2024;17(8):991.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"6","key":"960_CR32","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1111\/bjd.15237","volume":"176","author":"A Zarbo","year":"2017","unstructured":"Zarbo A, Belum VR, Sibaud V, Oudard S, Postow MA, Hsieh JJ, et al. Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors. Br J Dermatol. 2017;176(6):1649\u201352.","journal-title":"Br J Dermatol"},{"issue":"5","key":"960_CR33","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/j.jaad.2020.03.132","volume":"83","author":"AN Geisler","year":"2020","unstructured":"Geisler AN, Phillips GS, Barrios DM, Wu J, Leung DYM, Moy AP, et al. Immune checkpoint inhibitor-related dermatologic adverse events. J Am Acad Dermatol. 2020;83(5):1255\u201368.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"960_CR34","first-page":"147","volume":"81","author":"GA Severs","year":"2008","unstructured":"Severs GA, Griffin T, Werner-Wasik M. Cicatricial alopecia secondary to radiation therapy: case report and review of the literature. Cutis. 2008;81(2):147\u201353.","journal-title":"Cutis"},{"issue":"3","key":"960_CR35","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/pde.14995","volume":"39","author":"S Kessler","year":"2022","unstructured":"Kessler S, Marzooq A, Sood A, Beebe K, Walsh A, Montoya L, et al. Alopecia in children undergoing chemotherapy, radiation, and hematopoietic stem cell transplantation: scoping review and approach to management. Pediatr Dermatol. 2022;39(3):354\u201362.","journal-title":"Pediatr Dermatol"},{"issue":"3","key":"960_CR36","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.jaad.2013.10.034","volume":"70","author":"M Choi","year":"2014","unstructured":"Choi M, Kim MS, Park SY, Park GH, Jo SJ, Cho KH, et al. Clinical characteristics of chemotherapy-induced alopecia in childhood. J Am Acad Dermatol. 2014;70(3):499\u2013505.","journal-title":"J Am Acad Dermatol"},{"key":"960_CR37","unstructured":"Reti Anggraeni AD, Irawanto ME, Widhiati S, Riza M. Hair Shaft Alteration in Children Undergoing Chemotherapy. Leukemia. 2021;9:30."},{"issue":"3","key":"960_CR38","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s10549-024-07440-5","volume":"208","author":"AM Kuo","year":"2024","unstructured":"Kuo AM, Reingold RE, Ketosugbo KF, Pan A, Kraehenbuehl L, Dusza S, et al. Oral minoxidil for late alopecia in cancer survivors. Breast Cancer Res Treat. 2024;208(3):491\u20139.","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"960_CR39","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.ijrobp.2012.07.008","volume":"85","author":"IWEM van Dijk","year":"2013","unstructured":"van Dijk IWEM, Cardous-Ubbink MC, van der Pal HJH, Heinen RC, van Leeuwen FE, Oldenburger F, et al. Dose-effect relationships for adverse events after cranial radiation therapy in long-term childhood cancer survivors. Int J Radiat Oncol Biol Phys. 2013;85(3):768\u201375.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"960_CR40","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.7314\/APJCP.2016.17.4.1717","volume":"17","author":"S Gunawan","year":"2016","unstructured":"Gunawan S, Broeke CT, Ven P, Arnoldussen M, Kaspers G, Mostert S. Parental experiences with chemotherapy-induced alopecia among childhood cancer patients in Indonesia. Asian Pac J Cancer Prev. 2016;17(4):1717\u201323.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"20","key":"960_CR41","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1200\/JCO.2011.39.3611","volume":"30","author":"KE Kinahan","year":"2012","unstructured":"Kinahan KE, Sharp LK, Seidel K, Leisenring W, Didwania A, Lacouture ME, et al. Scarring, disfigurement, and quality of life in long-term survivors of childhood cancer: a report from the Childhood Cancer Survivor study. J Clin Oncol. 2012;30(20):2466\u201374.","journal-title":"J Clin Oncol"},{"issue":"5","key":"960_CR42","first-page":"3955","volume":"30","author":"A Versluis","year":"2022","unstructured":"Versluis A, van Alphen K, Dercksen W, de Haas H, van den Hurk C, Kaptein AA. \u201cDear hair loss\u201d-illness perceptions of female patients with chemotherapy-induced alopecia. Support Care Cancer. 2022;30(5):3955\u201363.","journal-title":"Support Care Cancer"},{"issue":"4","key":"960_CR43","first-page":"237","volume":"31","author":"S Kocan","year":"2023","unstructured":"Kocan S, Aktug C, Gursoy A. \u201cWho am I?\u201d A qualitative meta-synthesis of chemotherapy-induced alopecia and body image perception in breast cancer patients. Support Care Cancer. 2023;31(4):237.","journal-title":"Support Care Cancer"},{"key":"960_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejon.2020.101840","volume":"49","author":"V Boland","year":"2020","unstructured":"Boland V, Brady AM, Drury A. The physical, psychological and social experiences of alopecia among women receiving chemotherapy: an integrative literature review. Eur J Oncol Nurs. 2020;49: 101840.","journal-title":"Eur J Oncol Nurs"},{"issue":"8","key":"960_CR45","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1111\/jdv.18848","volume":"37","author":"M Prendke","year":"2023","unstructured":"Prendke M, Kanti-Schmidt V, Wilborn D, Hillmann K, Singh R, Vogt A, et al. Quality of life in children and adolescents with alopecia areata: a systematic review. J Eur Acad Dermatol Venereol. 2023;37(8):1521\u201334.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"960_CR46","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1159\/000466704","volume":"3","author":"T Christensen","year":"2017","unstructured":"Christensen T, Yang JS, Castelo-Soccio L. Bullying and quality of life in pediatric alopecia areata. Skin Append Disord. 2017;3(3):115\u20138.","journal-title":"Skin Append Disord."},{"issue":"2","key":"960_CR47","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.31432","volume":"72","author":"EJ Kim","year":"2025","unstructured":"Kim EJ, Hlobik M, Berbert L, Brace-O\u2019Neill J, Vrooman L, Huang JT. Impact of persistent alopecia on quality of life in childhood cancer and transplant survivors. Pediatr Blood Cancer. 2025;72(2): e31432.","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"960_CR48","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1111\/jocd.12308","volume":"16","author":"A Rossi","year":"2017","unstructured":"Rossi A, Fortuna MC, Caro G, Pranteda G, Garelli V, Pompili U, et al. Chemotherapy-induced alopecia management: clinical experience and practical advice. J Cosmet Dermatol. 2017;16(4):537\u201341.","journal-title":"J Cosmet Dermatol"},{"issue":"4","key":"960_CR49","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-015468","volume":"7","author":"K Montgomery","year":"2017","unstructured":"Montgomery K, White C, Thompson A. A mixed methods survey of social anxiety, anxiety, depression and wig use in alopecia. BMJ Open. 2017;7(4): e015468.","journal-title":"BMJ Open"},{"issue":"1","key":"960_CR50","doi-asserted-by":"publisher","DOI":"10.1097\/JW9.0000000000000075","volume":"9","author":"O Ezemma","year":"2023","unstructured":"Ezemma O, Devjani S, Lee A, Kelley KJ, Anderson L, Friedland N, et al. Patterns of insurance coverage for wigs in patients with alopecia areata: a cross-sectional survey. Int J Womens Dermatol. 2023;9(1): e075.","journal-title":"Int J Womens Dermatol."},{"issue":"3","key":"960_CR51","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.jaad.2024.11.013","volume":"92","author":"RW Kim","year":"2025","unstructured":"Kim RW, McClain W, Mesinkovska NA, Min MS. Legislative efforts to expand insurance coverage of wigs for individuals with medical causes of alopecia. J Am Acad Dermatol. 2025;92(3):663\u20135.","journal-title":"J Am Acad Dermatol"},{"key":"960_CR52","unstructured":"H.R.4304 - 118th Congress (2023-2024): To amend title XVIII of the Social Security Act to provide coverage for wigs as durable medical equipment under the Medicare program, and for other purposes. (2023, June 12). https:\/\/www.congress.gov\/bill\/118th-congress\/house-bill\/4034\/text."},{"key":"960_CR53","unstructured":"S.1922 - 118th Congress (2023-2024): A bill to amend title XVIII of the Social Security Act to provide coverage for wigs as durable medical equipment under the Medicare program, and for other purposes. (2023, June 12). https:\/\/www.congress.gov\/bill\/118th-congress\/senate-bill\/1922."},{"key":"960_CR54","unstructured":"Children's Hospital of Philadelphia. Managing alopecia in children with cancer. https:\/\/www.chop.edu\/conditions-diseases\/managing-alopecia-children-cancer. Accessed 27 Oct 2024."},{"key":"960_CR55","unstructured":"St Jude Children's Research Hospital. Hair loss. https:\/\/together.stjude.org\/en-us\/diagnosis-treatment\/side-effects\/hair-loss.html. Accessed 27 Oct 2024."},{"key":"960_CR56","unstructured":"Memorial Sloan Kettering Cancer Center. Hair loss and your cancer treatment. 2024. https:\/\/www.mskcc.org\/cancer-care\/patient-education\/hair-loss-cancer-treatment. Accessed 27 Oct 2024."},{"key":"960_CR57","volume-title":"Handbook of hair in health and disease","author":"VR Preedy","year":"2011","unstructured":"Preedy VR. Shampoo compositions. In: Preedy VR, editor. Handbook of hair in health and disease. Wageningen Academic Publishers: Wageningen; 2011."},{"issue":"4","key":"960_CR58","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/pde.13176","volume":"34","author":"KA Aschenbeck","year":"2017","unstructured":"Aschenbeck KA, McFarland SL, Hordinsky MK, Lindgren BR, Farah RS. Importance of group therapeutic support for family members of children with alopecia areata: a cross-sectional survey study. Pediatr Dermatol. 2017;34(4):427\u201332.","journal-title":"Pediatr Dermatol"},{"issue":"1","key":"960_CR59","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.jaad.2020.06.047","volume":"85","author":"A Toussi","year":"2021","unstructured":"Toussi A, Barton VR, Le ST, Agbai ON, Kiuru M. Psychosocial and psychiatric comorbidities and health-related quality of life in alopecia areata: a systematic review. J Am Acad Dermatol. 2021;85(1):162\u201375.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"960_CR60","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.abd.2020.03.005","volume":"95","author":"GB Silva","year":"2020","unstructured":"Silva GB, Ciccolini K, Donati A, Hurk CVD. Scalp cooling to prevent chemotherapy-induced alopecia. An Bras Dermatol. 2020;95(5):631\u20137.","journal-title":"An Bras Dermatol"},{"issue":"11","key":"960_CR61","first-page":"6943","volume":"29","author":"S Wang","year":"2021","unstructured":"Wang S, Yang T, Shen A, Qiang W, Zhao Z, Zhang F. The scalp cooling therapy for hair loss in breast cancer patients undergoing chemotherapy: a systematic review and meta-analysis. Support Care Cancer. 2021;29(11):6943\u201356.","journal-title":"Support Care Cancer"},{"issue":"2","key":"960_CR62","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s10549-017-4185-9","volume":"163","author":"HS Rugo","year":"2017","unstructured":"Rugo HS, Melin SA, Voigt J. Scalp cooling with adjuvant\/neoadjuvant chemotherapy for breast cancer and the risk of scalp metastases: systematic review and meta-analysis. Breast Cancer Res Treat. 2017;163(2):199\u2013205.","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"960_CR63","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s10549-014-3231-0","volume":"149","author":"J Lemieux","year":"2015","unstructured":"Lemieux J, Provencher L, Perron L, Brisson J, Amireault C, Blanchette C, et al. No effect of scalp cooling on survival among women with breast cancer. Breast Cancer Res Treat. 2015;149(1):263\u20138.","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"960_CR64","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1001\/jama.2016.20939","volume":"317","author":"J Nangia","year":"2017","unstructured":"Nangia J, Wang T, Osborne C, Niravath P, Otte K, Papish S, et al. Effect of a scalp cooling device on alopecia in women undergoing chemotherapy for breast cancer: the SCALP randomized clinical trial. JAMA. 2017;317(6):596\u2013605.","journal-title":"JAMA"},{"issue":"9262","key":"960_CR65","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1016\/S0140-6736(00)04293-8","volume":"357","author":"SA Forsberg","year":"2001","unstructured":"Forsberg SA. Scalp cooling therapy and cytotoxic treatment. Lancet. 2001;357(9262):1134.","journal-title":"Lancet"},{"issue":"1","key":"960_CR66","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1002\/1097-0142(19840701)54:1<34::AID-CNCR2820540109>3.0.CO;2-W","volume":"54","author":"B Satterwhite","year":"1984","unstructured":"Satterwhite B, Zimm S. The use of scalp hypothermia in the prevention of doxorubicin-induced hair loss. Cancer. 1984;54(1):34\u20137.","journal-title":"Cancer"},{"issue":"6","key":"960_CR67","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/S0959-8049(00)00012-5","volume":"36","author":"P Katsimbri","year":"2000","unstructured":"Katsimbri P, Bamias A, Pavlidis N. Prevention of chemotherapy-induced alopecia using an effective scalp cooling system. Eur J Cancer. 2000;36(6):766\u201371.","journal-title":"Eur J Cancer"},{"issue":"6","key":"960_CR68","first-page":"371","volume":"11","author":"M Ridderheim","year":"2003","unstructured":"Ridderheim M, Bjurberg M, Gustavsson A. Scalp hypothermia to prevent chemotherapy-induced alopecia is effective and safe: a pilot study of a new digitized scalp-cooling system used in 74 patients. Support Care Cancer. 2003;11(6):371\u20137.","journal-title":"Support Care Cancer"},{"issue":"7\u20138","key":"960_CR69","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1159\/000523759","volume":"45","author":"S Keim","year":"2022","unstructured":"Keim S, Hempel L, Ebner F, Retzer-Lidl M, Wohlmuth K, Hempel D, et al. Scalp cooling for prevention of chemotherapy-induced alopecia for women and men with various cancer entities: a two-year survey of an outpatient cancer center in Germany. Oncol Res Treat. 2022;45(7\u20138):395\u20139.","journal-title":"Oncol Res Treat."},{"key":"960_CR70","doi-asserted-by":"publisher","first-page":"S279","DOI":"10.1016\/S2152-2650(24)01129-7","volume":"24","author":"R Kumar","year":"2024","unstructured":"Kumar R, Gupta AK, Jana M, Bansal S, Prakash S, Meena JP, et al. ALL-661 The effect of scalp cooling in ameliorating chemotherapy-induced alopecia in children with acute lymphoblastic leukemia: a prospective nonrandomized trial. Clin Lymphoma Myeloma Leukemia. 2024;24:S279.","journal-title":"Clin Lymphoma Myeloma Leukemia."},{"key":"960_CR71","unstructured":"ClincalTrials.gov. NCT04764357. COOLCAP: Pilot Study Of Cold Cap Therapy For Prevention of Hairloss in Pediatric Patients Receiving Chemotherapy For Non-Malignant Indications and Solid Tumors. Updated June 5, 2025. https:\/\/clinicaltrials.gov\/study\/NCT04764357."},{"issue":"4","key":"960_CR72","doi-asserted-by":"publisher","first-page":"3609","DOI":"10.3390\/curroncol30040275","volume":"30","author":"TC Wikramanayake","year":"2023","unstructured":"Wikramanayake TC, Haberland NI, Akhundlu A, Laboy Nieves A, Miteva M. Prevention and treatment of chemotherapy-induced alopecia: what is available and what is coming? Curr Oncol. 2023;30(4):3609\u201326.","journal-title":"Curr Oncol"},{"issue":"3","key":"960_CR73","doi-asserted-by":"publisher","DOI":"10.5826\/dpc.1003a74","volume":"10","author":"A Rossi","year":"2020","unstructured":"Rossi A, Caro G, Fortuna MC, Pigliacelli F, D\u2019Arino A, Carlesimo M. Prevention and treatment of chemotherapy-induced alopecia. Dermatol Pract Concept. 2020;10(3): e2020074.","journal-title":"Dermatol Pract Concept."},{"issue":"1","key":"960_CR74","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/ijc.28961","volume":"136","author":"CM Soref","year":"2015","unstructured":"Soref CM, Fahl WE. A new strategy to prevent chemotherapy and radiotherapy-induced alopecia using topically applied vasoconstrictor. Int J Cancer. 2015;136(1):195\u2013203.","journal-title":"Int J Cancer"},{"issue":"11","key":"960_CR75","doi-asserted-by":"publisher","first-page":"3407","DOI":"10.1111\/jocd.14421","volume":"20","author":"K Saini","year":"2021","unstructured":"Saini K, Mysore V. Role of vitamin D in hair loss: a short review. J Cosmet Dermatol. 2021;20(11):3407\u201314.","journal-title":"J Cosmet Dermatol"},{"issue":"1","key":"960_CR76","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s10549-020-06005-6","volume":"186","author":"ME Lacouture","year":"2021","unstructured":"Lacouture ME, Dion H, Ravipaty S, Jimenez JJ, Thapa K, Grund EM, et al. A phase I safety study of topical calcitriol (BPM31543) for the prevention of chemotherapy-induced alopecia. Breast Cancer Res Treat. 2021;186(1):107\u201314.","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"960_CR77","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/j.1365-2133.2005.06608.x","volume":"153","author":"TO Bleiker","year":"2005","unstructured":"Bleiker TO, Nicolaou N, Traulsen J, Hutchinson PE. \u201cAtrophic telogen effluvium\u201d from cytotoxic drugs and a randomized controlled trial to investigate the possible protective effect of pretreatment with a topical vitamin D analogue in humans. Br J Dermatol. 2005;153(1):103\u201312.","journal-title":"Br J Dermatol"},{"issue":"4","key":"960_CR78","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1097\/00001813-199904000-00007","volume":"10","author":"M Hidalgo","year":"1999","unstructured":"Hidalgo M, Rinaldi D, Medina G, Griffin T, Turner J, Von Hoff DD. A phase I trial of topical topitriol (calcitriol, 1,25-dihydroxyvitamin D3) to prevent chemotherapy-induced alopecia. Anticancer Drugs. 1999;10(4):393\u20135.","journal-title":"Anticancer Drugs"},{"issue":"6","key":"960_CR79","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1096\/fj.07-099424","volume":"22","author":"K Shorter","year":"2008","unstructured":"Shorter K, Farjo NP, Picksley SM, Randall VA. Human hair follicles contain two forms of ATP-sensitive potassium channels, only one of which is sensitive to minoxidil. FASEB J. 2008;22(6):1725\u201336.","journal-title":"FASEB J"},{"issue":"5","key":"960_CR80","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/j.1346-8138.1990.tb01641.x","volume":"17","author":"O Mori","year":"1990","unstructured":"Mori O, Uno H. The effect of topical minoxidil on hair follicular cycles of rats. J Dermatol. 1990;17(5):276\u201381.","journal-title":"J Dermatol"},{"issue":"7","key":"960_CR81","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1111\/j.1365-4362.1995.tb00612.x","volume":"34","author":"AM Hussein","year":"1995","unstructured":"Hussein AM. Protection against cytosine arabinoside-induced alopecia by minoxidil in a rat animal model. Int J Dermatol. 1995;34(7):470\u20133.","journal-title":"Int J Dermatol"},{"issue":"1","key":"960_CR82","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/S0190-9622(96)90500-9","volume":"35","author":"M Duvic","year":"1996","unstructured":"Duvic M, Lemak NA, Valero V, Hymes SR, Farmer KL, Hortobagyi GN, et al. A randomized trial of minoxidil in chemotherapy-induced alopecia. J Am Acad Dermatol. 1996;35(1):74\u20138.","journal-title":"J Am Acad Dermatol"},{"key":"960_CR83","first-page":"2936","volume":"392","author":"C Granai","year":"1991","unstructured":"Granai C, Frederickson H, Gajewski W, Goodman A, Goldstein A, Baden H. The use of minoxidil to attempt to prevent alopecia during chemotherapy for gynecologic malignancies. Eur J Gynaec Oncol. 1991;392:2936.","journal-title":"Eur J Gynaec Oncol."},{"issue":"8","key":"960_CR84","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1093\/oxfordjournals.annonc.a058986","volume":"5","author":"R Rodriguez","year":"1994","unstructured":"Rodriguez R, Machiavelli M, Leone B, Romero A, Cuevas MA, Langhi M, et al. Minoxidil (Mx) as a prophylaxis of doxorubicin-induced alopecia. Ann Oncol. 1994;5(8):769\u201370.","journal-title":"Ann Oncol"},{"issue":"1","key":"960_CR85","doi-asserted-by":"publisher","first-page":"4349","DOI":"10.1038\/s41598-024-53054-8","volume":"14","author":"JW Lee","year":"2024","unstructured":"Lee JW, Kang J, Choi JY, Hong KT, Kang HJ, Kwon O. Topical minoxidil and dietary supplement for the treatment of chemotherapy-induced alopecia in childhood: a retrospective cohort study. Sci Rep. 2024;14(1):4349.","journal-title":"Sci Rep"},{"issue":"4","key":"960_CR86","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.abd.2023.07.010","volume":"99","author":"RR Melo","year":"2024","unstructured":"Melo RR, Cortez de Almeida RF, Lemes LR, Frattini Junior S, M\u00fcller Ramos P, Melo DF. Low-dose oral minoxidil for persistent chemotherapy and radiotherapy-induced alopecia in a pediatric female patient. An Bras Dermatol. 2024;99(4):635\u20137.","journal-title":"An Bras Dermatol"},{"issue":"5","key":"960_CR87","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1016\/j.jaad.2022.12.005","volume":"88","author":"J Kang","year":"2023","unstructured":"Kang J, Lee JW, Kwon O. Efficacy of low-dose oral minoxidil in the management of anticancer therapy-induced alopecia in patients with breast cancer: a retrospective cohort study. J Am Acad Dermatol. 2023;88(5):1170\u20133.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"960_CR88","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.jaad.2024.11.048","volume":"92","author":"D Zaminski","year":"2025","unstructured":"Zaminski D, Sikora M, Nohria A, Desai D, Buontempo M, Caplan AS, et al. Tolerability and effectiveness of low-dose oral minoxidil for alopecia in patients with breast cancer: a retrospective cohort study. J Am Acad Dermatol. 2025;92(4):906\u20139.","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"960_CR89","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1046\/j.1524-4725.1999.99004.x","volume":"25","author":"P Rosati","year":"1999","unstructured":"Rosati P, Bergamo A. Allogenic hair transplant in a bone marrow transplant recipient. Dermatol Surg. 1999;25(8):664\u20135.","journal-title":"Dermatol Surg"},{"issue":"2","key":"960_CR90","first-page":"236","volume":"33","author":"S Tommy Hwang","year":"2007","unstructured":"Tommy Hwang S, Kim H, Lee WJ, Kim DW, Kim JC, Kook H, et al. Successful hair transplantation from a bone marrow transplantation donor to a bone marrow transplantation recipient. Dermatol Surg. 2007;33(2):236\u20138.","journal-title":"Dermatol Surg"},{"key":"960_CR91","unstructured":"ClincalTrials.gov. NCT05778825. A Pilot Study of Oral Minoxidil for the Treatment of Persistent Hair Loss in Pediatric, Adolescent, and Young Adult Cancer Survivors. Updated July 19, 2024. https:\/\/clinicaltrials.gov\/study\/NCT05778825."},{"issue":"2","key":"960_CR92","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/ijd.16373","volume":"62","author":"JM John","year":"2023","unstructured":"John JM, Sinclair RD. Systemic minoxidil for hair disorders in pediatric patients: a safety and tolerability review. Int J Dermatol. 2023;62(2):257\u20139.","journal-title":"Int J Dermatol"},{"issue":"2","key":"960_CR93","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.jaad.2022.06.1195","volume":"88","author":"JM John","year":"2023","unstructured":"John JM, Sinclair R. Safety and tolerability of low-dose oral minoxidil in adolescents: a retrospective review. J Am Acad Dermatol. 2023;88(2):502\u20134.","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"960_CR94","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1007\/s13555-024-01197-x","volume":"14","author":"KN Williams","year":"2024","unstructured":"Williams KN, Olukoga CTY, Tosti A. Evaluation of the safety and effectiveness of oral minoxidil in children: a systematic review. Dermatol Ther (Heidelb). 2024;14(7):1709\u201327.","journal-title":"Dermatol Ther (Heidelb)."}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-025-00960-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40257-025-00960-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-025-00960-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T20:03:04Z","timestamp":1757966584000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40257-025-00960-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,30]]},"references-count":94,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["960"],"URL":"https:\/\/doi.org\/10.1007\/s40257-025-00960-w","relation":{},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"value":"1175-0561","type":"print"},{"value":"1179-1888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,30]]},"assertion":[{"value":"8 June 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No funds, grants, or other support were received for the preparation of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Mario E. Lacouture is an investigator for Paxman Coolers Ltd. Caitlin A. Kearney, Ciara A. Maguire, Vikash S. Oza, Christina S. Oh, Michael A. Occidental, Jerry Shapiro, Seth J. Orlow, Chana L. Glasser, Nikita R. Lakdawala, and Kristen I. Lo Sicco have no conflicts of interest that are directly relevant to the content of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"The authors attest to obtaining written patient consent for the publication of patient photographs or other identifiable material, with the understanding that this information may be publicly available.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and Material"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"Conceptualization: KIL, CAK, CAM; literature review: CAK, CAM; drafting of the manuscript: CAK, CAM, CSO; critical revision of the manuscript: VSO, MAO, JS, SJO, CLG, MEL, NRL, KIL; supervision: NRL, KIL. All authors read and approved the final manuscript.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 Contributions"}}]}}